关注
Katsiaryna Prystupa
Katsiaryna Prystupa
Deutsches Diabetes-Zentrum (DDZ)
在 ddz.de 的电子邮件经过验证
标题
引用次数
引用次数
年份
Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine
DK Tobias, J Merino, A Ahmad, C Aiken, JL Benham, D Bodhini, AL Clark, ...
Nature medicine 29 (10), 2438-2457, 2023
772023
Precision subclassification of type 2 diabetes: a systematic review
S Misra, R Wagner, B Ozkan, M Schön, M Sevilla-Gonzalez, K Prystupa, ...
Communications medicine 3 (1), 138, 2023
292023
Analysis of type 2 diabetes heterogeneity with a tree-like representation: insights from the prospective German Diabetes Study and the LURIC cohort
M Schön, K Prystupa, T Mori, OP Zaharia, K Bódis, M Bombrich, C Möser, ...
The Lancet Diabetes & Endocrinology 12 (2), 119-131, 2024
92024
Brain insulin action on peripheral insulin sensitivity in women depends on menstrual cycle phase
J Hummel, C Benkendorff, L Fritsche, K Prystupa, A Vosseler, ...
Nature metabolism 5 (9), 1475-1482, 2023
92023
Comprehensive validation of fasting-based and oral glucose tolerance test–based indices of insulin secretion against gold standard measures
K Prystupa, R Renklint, Y Chninou, J Otten, L Fritsche, S Hoerber, A Peter, ...
BMJ Open Diabetes Research and Care 10 (5), e002909, 2022
72022
Clusters of prediabetes and type 2 diabetes stratify all-cause mortality in a cohort of participants undergoing invasive coronary diagnostics
K Prystupa, GE Delgado, AP Moissl, ME Kleber, AL Birkenfeld, M Heni, ...
Cardiovascular Diabetology 22 (1), 211, 2023
42023
Systematic review of precision subclassification of type 2 diabetes
S Misra, R Wagner, B Ozkan, M Schön, M Sevilla-Gonzalez, K Prystupa, ...
medRxiv, 2023.04. 19.23288577, 2023
32023
Interscapular fat is associated with impaired glucose tolerance and insulin resistance independent of visceral fat mass
A Vosseler, J Machann, L Fritsche, K Prystupa, C Kübler, HU Häring, ...
Obesity 30 (11), 2233-2241, 2022
22022
Postprandial Dynamics of Proglucagon Cleavage Products and Their Relation to Metabolic Health
R Wagner, SS Eckstein, L Fritsche, K Prystupa, S Hörber, HU Häring, ...
Frontiers in Endocrinology 13, 892677, 2022
12022
Comprehensive validation of fasting-and oral glucose tolerance test-based indices of insulin secretion against gold-standard measures
K Prystupa, R Renklint, Y Chninou, J Otten, L Fritsche, S Hörber, A Peter, ...
medRxiv, 2022.04. 14.22273491, 2022
12022
Blood coagulation in Prediabetes clusters–impact on all-cause mortality in individuals undergoing coronary angiography
S Hörber, K Prystupa, J Jacoby, A Fritsche, ME Kleber, AP Moissl, ...
Cardiovascular Diabetology 23 (1), 306, 2024
2024
Prädiabetes: differenzierte Betrachtung von Subtypen, Risiken und Pathomechanismen
K Prystupa, R Wagner
Die Diabetologie, 1-4, 2024
2024
1545-P: Differences in Brain Anatomy between Diabetes Endotypes—Results from the UK-Biobank
M CERRAI CERONI, J HUMMEL, K PRYSTUPA, HP MÜLLER, ...
Diabetes 73 (Supplement_1), 2024
2024
508-P: The Metabolic Phenome of the Hepatoprotective HSD17B13 Splice Variant rs72613567: TA Suggests Higher Lactate Clearance
DM MENDEZ CARDENAS, K BÓDIS, K PRYSTUPA, I YURCHENKO, ...
Diabetes 73 (Supplement_1), 2024
2024
345-OR: Beyond Size Matters—The Impact of Pancreatic Volume and Pancreatic Fat on Type 2 Diabetes
H YAMAZAKI, SI TAUCHI, M DOHKE, N HANAWA, Y KODAMA, ...
Diabetes 73 (Supplement_1), 2024
2024
1335-P: Insulin-Sensitive and Resistant Endotypes in Persons With and Without Recent-Onset Diabetes and Their Association with Diabetes-Related Outcomes
K BÓDIS, K PRYSTUPA, OP ZAHARIA, M SCHÖN, C MÖSER, ...
Diabetes 73 (Supplement_1), 2024
2024
460-P: Dual Role of Factor XI in Mortality and Diabetes—Insights from the Ludwigshafen Risk and Cardiovascular Health Study
K PRYSTUPA, M HENI, S HÖRBER, A PETER, P HELLSTERN, M KELM, ...
Diabetes 73 (Supplement_1), 2024
2024
1694-P: Subphenotype-Dependent Benefits of Bariatric Surgery in Data-Driven Clusters of Individuals at Risk for Type 2 Diabetes
L SANDFORTH, V RAVERDY, A SANDFORTH, P BAUVIN, ...
Diabetes 73 (Supplement_1), 2024
2024
Insulinsensitive und-resistente Endotypen bei Personen mit und ohne neu diagnostiziertem Diabetes und deren Assoziationen mit diabetesbezogenen Komorbiditäten
KB Bódis, K Prystupa, OP Zaharia, M Schön, C Möser, I Yurchenko, ...
Diabetologie und Stoffwechsel 19 (S 01), FV 01, 2024
2024
Erhöhte Laktat-Elimination als metabolisches Merkmal der hepatoprotektiven HSD17B13-Spleißvariante rs72613567: TA
DMM Cardenas, KB Bódis, M Bombrich, K Prystupa, I Yurchenko, ...
Diabetologie und Stoffwechsel 19 (S 01), FV 10, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–20